ESG

The Italian pharma giant appoints a global health policy heavyweight, signaling a strategic pivot towards tackling complex global challenges and a new era.

With key leadership hires, Hudson Valley Property Group is scaling up to meet soaring investor demand for impact-driven affordable housing preservation.

Vancouver's ME Therapeutics will unveil its in-vivo immune reprogramming technology, a potential cancer treatment game-changer, to global investors.

A massive $250M investment could replace a 40-pill daily burden with a single tablet for patients with pancreatic insufficiency, disrupting a market in crisis.

A new survey finds most mothers reject the 'routine' label, feeling strong in daily acts. One FemTech firm is now championing a shift from sacrifice to celebration.

From the makers of the 'World's Best Tequila,' a new Reposado redefines aging with a unique blend of Sauternes, Sherry, and Bourbon casks.

Seattle nonprofit Ryther launches Juniper, an intensive program for teens, addressing a critical gap in care for older adolescents with mood and anxiety.

A five-year exclusive deal for MilliporeSigma to test Genetix's gene therapies is set to ensure safety and expand access to one-time cures for rare diseases.

A historic UN petition reframes the Xinjiang crisis, accusing China of colonialism and demanding decolonization for East Turkistan after years of failed diplomacy.

A leading scientific body is ditching 'longevity' for 'geroscience,' aiming to bring scientific rigor to a field rife with hype and misinformation.

Chicago Atlantic posts stable Q1 distributable earnings but a sharp drop in net income due to credit provisions, banking on a cannabis rescheduling windfall.

With backing from an NBA owner, snacking dough brand Doich hires a new COO to lead its push into major grocery chains and the 'better-for-you' market.

As Texas booms, Oncor is spending billions on the grid. Find out how the state's economic expansion will directly impact the cost of your electricity.

A new drug shows major promise for a painful heart condition, with pivotal study results accepted by a top journal and a final-stage trial speeding ahead.

An unlikely alliance of sheriffs, tech experts, and justice-impacted leaders is forging a new path to reduce recidivism and solve labor shortages.

A landmark clinical trial suggests a different form of folate may be better for pregnancy, reducing a controversial byproduct without sacrificing key benefits.

As REX American Resources prepares for a key investor conference, its major bet on carbon capture technology is under the microscope. Will it pay off?

Quebec biotech firm Aplantex secures $5M to scale its unique green technology, moving from research to industrial production of sustainable ingredients.

The food giant's Q1 results soar past expectations, validating its strategic pivot away from pork and focus on operational efficiency and brand power.

A free virtual summit unites 20+ experts to share science-based strategies, blending traditional and lifestyle medicine to fight preventable blindness.